Archives: Recent News

Visionary Media Group (VMG), a wholly-owned subsidiary of Visionary Private Equity Group, through its joint venture with BMG, is pleased to announce new film score asset agreements with several independent production companies.

• During the first quarter of 2017, OWP management has been focused on the following activities to position the company for a commercial relaunch later this year; (1) sourcing and manufacturing additional FDA approved products, (2) pre-marketing to both neurologists and psychiatrists, and (3) tightly controlling spending and raising additional capital to support planned growth.

Visionary Private Equity Group is happy to report that Visionary Technologies (VT), a technology platform portfolio company of VPEG, has entered into a Commercial Revenue Sharing Agreement with Smartrac Technology Group, the world’s largest RFID (‘smart chip’) technology provider.

BioHiTech Global, Inc. (OTCQB: BHTG), a green technology company that develops and deploys innovative and disruptive waste management technologies, reported financial results for the first quarter of 2017 ended March 31, 2017.

Michigan Potash Company (“MPC”) has officially received the US EPA’s Underground Injection Control Class III Area Permit.

Founder Jim McCarvill announced this week that current total funding engagements for McCarvill Capital Partners represent between $5 and 6 billion dollars in potential new limited partner commitments, a high water mark for the firm.

Forever Oceans’ CEO, Jason Heckathorn, announced that he received a binding development agreement for six (or more) farms in the North African region that includes Morocco.

The planned facility in New Windsor, NY, approximately 60 miles north of New York City, will use patented process to reduce greenhouse gas emissions and produce EPA recognized Solid Recovered Fuel

As we look to round out the current capital raise and as previously communicated, I planned to form a Board of Directors…

BioQ Pharma Incorporated, a specialty pharmaceutical company, and Lunatus, a company focused on building and developing profitable pharmaceutical brands in Arabian Gulf and Middle East markets, today announced the addition of a third ready-to-use infusible pharmaceutical product to their existing strategic distribution, supply, and commercial agreement.